Colorectal cancer prevention and treatment

被引：68
作者：
Boland, CR
Sinicrope, FA
Brenner, DE
Carethers, JM
机构：
[1] Univ Calif San Diego, Ctr Canc, Dept Med, Div Gastroenterol, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Sch Med, San Diego VA Med Ctr, La Jolla, CA 92093 USA
[3] Univ Texas, MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol & Digest Dis, Houston, TX 77030 USA
[4] Univ Michigan, Sch Med, Dept Internal Med, Div Hematol Oncol, Ann Arbor, MI 48109 USA
来源：
GASTROENTEROLOGY | 2000年 / 118卷 / 02期
关键词：
D O I：
10.1016/S0016-5085(00)70010-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：S115 / S128
页数：14
相关论文
共 87 条
[1]   Bimonthly high-dose leucovorin, 5-fluorouracil infusion and oxaliplatin (FOLFOX3) for metastatic colorectal cancer resistant to the same leucovorin and 5-fluorouracil regimen [J].
André, T ;
Louvet, C ;
Raymond, E ;
Tournigand, C ;
de Gramont, A .
ANNALS OF ONCOLOGY, 1998, 9 (11) :1251-1253
[2]   5-ETHYNYLURACIL (776C85) - A POTENT MODULATOR OF THE PHARMACOKINETICS AND ANTITUMOR EFFICACY OF 5-FLUOROURACIL [J].
BACCANARI, DP ;
DAVIS, ST ;
KNICK, VC ;
SPECTOR, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (23) :11064-11068
[3]   Pharmacokinetic, oral bioavailability, and safety study of fluorouracil in patients treated with 776C85, an inactivator of dihydropyrimidine dehydrogenase [J].
Baker, SD ;
Khor, SP ;
Adjei, AA ;
Doucette, M ;
Spector, T ;
Donehower, RC ;
Grochow, LB ;
Sartorius, SE ;
Noe, DA ;
Hohneker, JA ;
Rowinsky, EK .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (12) :3085-3096
[4]   Chemoprevention of spontaneous intestinal adenomas in the adenomatous polyposis coli Min mouse model with aspirin [J].
Barnes, CJ ;
Lee, M .
GASTROENTEROLOGY, 1998, 114 (05) :873-877
[5]   Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients [J].
Bécouarn, Y ;
Ychou, M ;
Ducreux, M ;
Borel, C ;
Bertheault-Cvitkovic, F ;
Seitz, JF ;
Nasca, S ;
Nguyen, TD ;
Paillot, B ;
Raoul, JL ;
Duffour, J ;
Fandi, A ;
Dupont-André, G ;
Rougier, P .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) :2739-2744
[6]  
Bleiberg H, 1998, SEMIN ONCOL, V25, P32
[7]  
BOLAND CR, 1998, GENETIC BASIS HUMAN, P333
[8]  
BOLAND CR, 1999, TXB GASTROENTEROLOGY, P2023
[9]   RANDOMIZED COMPARISON OF 2 SCHEDULES OF FLUOROURACIL AND LEUCOVORIN IN THE TREATMENT OF ADVANCED COLORECTAL-CANCER [J].
BUROKER, TR ;
OCONNELL, MJ ;
WIEAND, HS ;
KROOK, JE ;
GERSTNER, JB ;
MAILLIARD, JA ;
SCHAEFER, PL ;
LEVITT, R ;
KARDINAL, CG ;
GESME, DH .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (01) :14-20
[10]  
Buyse M, 1996, J NATL CANCER I, V88, P252
123456789